Update of a phase 1 study of intravenous CCI-779 given in combination with interferon-α to patients with advanced renal cell carcinoma.

被引：0
|
作者：
Smith, JW
Ko, YJ
Dutcher, J
Hudes, G
Escudier, B
Motzer, R
Négrier, S
Duclos, B
Galand, L
Strauss, L
机构：
[1] Providence Portland Med Ctr, Earle Chiles Res Inst, Portland, OR USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Our Lady Mercy Canc Ctr, Bronx, NY USA
[4] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[5] Inst Gustave Roussy, Villejuif, France
[6] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[7] Ctr Leon Berard, F-69373 Lyon, France
[8] CHU Hautepierre, F-67098 Strasbourg, France
[9] Wyeth Ayerst Res, Paris, France
[10] Wyeth Ayerst Res, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4513
引用
收藏
页码：385S / 385S
页数：1
相关论文
共 50 条
  • [41] Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies
    Janice P. Dutcher
    Paul de Souza
    David McDermott
    Robert A. Figlin
    Anna Berkenblit
    Alexandra Thiele
    Mizue Krygowski
    Andrew Strahs
    Jay Feingold
    Gary Hudes
    Medical Oncology, 2009, 26 : 202 - 209
  • [42] Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies
    Dutcher, Janice P.
    de Souza, Paul
    McDermott, David
    Figlin, Robert A.
    Berkenblit, Anna
    Thiele, Alexandra
    Krygowski, Mizue
    Strahs, Andrew
    Feingold, Jay
    Hudes, Gary
    MEDICAL ONCOLOGY, 2009, 26 (02) : 202 - 209
  • [43] A PHASE-II STUDY OF VINBLASTINE IN COMBINATION WITH ACRIVASTINE IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
    BERLIN, J
    KING, AC
    TUTSCH, K
    FINDLAY, JW
    KOHLER, P
    COLLIER, M
    CLENDENINN, NJ
    WILDING, G
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (02) : 137 - 141
  • [44] A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma
    Rini, B.
    Redman, B.
    Garcia, J. A.
    Burris, H. A., III
    Li, S.
    Fandi, A.
    Beck, R.
    Jungnelius, U.
    Infante, J. R.
    ANNALS OF ONCOLOGY, 2014, 25 (09) : 1794 - 1799
  • [45] Phase 2 study of neoadjuvant cabozantinib in patients with locally advanced non-metastatic clear cell renal cell carcinoma.
    Bilen, Mehmet Asim
    Liu, Yuan
    Nazha, Bassel
    Brown, Jacqueline T.
    Osunkoya, Adeboya O.
    Williams, Sierra
    Session, Wilena
    Yantorni, Lauren Beth
    Russler, Greta
    Caulfield, Sarah
    Joshi, Shreyas S.
    Narayan, Vikram M.
    Filson, Christopher Paul
    Ogan, Kenneth
    Kucuk, Omer
    Carthon, Bradley Curtis
    Kissick, Haydn
    Master, Viraj A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [46] Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma
    Huie, M
    Oettel, K
    Van Ummersen, L
    Kim, KM
    Zhang, YL
    Staab, MJ
    Horvath, D
    Marnocha, R
    Douglas, J
    Drezen, A
    Alberti, D
    Wilding, G
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (03) : 255 - 260
  • [47] Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinoma
    Michael Huie
    Kurt Oettel
    Lynn Van Ummersen
    Kyung Mann Kim
    Yulin Zhang
    Mary Jane Staab
    Dottie Horvath
    Rebecca Marnocha
    Jeff Douglas
    Amy Drezen
    Dona Alberti
    George Wilding
    Investigational New Drugs, 2006, 24 : 255 - 260
  • [48] Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
    Lu, YS
    Hsu, CU
    Li, CC
    Kuo, SH
    Yeh, KH
    Yang, CH
    Hsu, CH
    Wu, CY
    Cheng, AL
    HEPATO-GASTROENTEROLOGY, 2004, 51 (57) : 815 - 819
  • [49] Analysis of PTEN and HIF-1α and Correlation With Efficacy in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus Versus Interferon-α
    Figlin, Robert A.
    de Souza, Paul
    McDermott, David
    Dutcher, Janice P.
    Berkenblit, Anna
    Thiele, Alexandra
    Krygowski, Mizue
    Strahs, Andrew
    Feingold, Jay
    Boni, Joseph
    Hudes, Gary
    CANCER, 2009, 115 (16) : 3651 - 3660
  • [50] Long term follow-up of outpatients treated with subcutaneous interleukin-2, interferon-α and intravenous 5-fluorouracil for advanced renal carcinoma.
    Popescu, RA
    Hirst, M
    Hayward, K
    Leahy, MG
    Patel, PM
    Selby, PJ
    ANNALS OF ONCOLOGY, 2000, 11 : 76 - 76
12345